Location: Home
  • search
  • go
  • Relate News
  • 11/3/202245 Orphan Drugs Included in China's Latest National Drug Reimbursemne...
  • 11/2/2022CDE Issues the Technical Guidelines for Design and Evaluation of Pedia...
  • 11/2/2022NMPA Announces Package Insert Revision of Liver Hydrolyzed Peptide Inj...
  • 11/1/2022NMPA Initiates New Certification Documents for APIs and Drug Exports
  • 11/1/2022TPG Capital Asia Acquires Majority Stake in iNova Pharmaceuticals
  • 11/1/2022Pharmaniaga Partners JD.com to Enter China Healthcare Market
  • 11/1/2022Invincible Diabetes Turns APAC Into Pharma Goldmine (BioSpectrum)
  • 11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...
  • 10/31/2022Yes! It's Now Time to Reconfigure Your China Business Model Again
  • 10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)
  • 10/31/2022Financial-related Company News Digest (October 2022)
  • 10/31/2022Novartis Abandons US PD-1 Submission Plan for Tislelizumab
  • 10/31/2022NMPA Suspends Import, Sales and Use of GSK's Prostate Cancer Drug Avod...
  • 10/31/2022JPO Bans GSK from Participating in China's National Level Centralized ...
  • 10/30/2022Ascletis Pharma Ends Down After Pfizer Supply Deal Sent Stock Soaring
  • 10/28/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (64...
  • 10/28/2022Recent Executive Moves
  • 10/28/2022Drug R&D and Product Registration News Digest October 2022 (3)
  • 10/28/2022XtalPi Announces Research Collaboration with Janssen
  • 10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations
  • 10/27/2022CDE Solicits Comments on Draft Work Standards for Review of Drug Clini...
  • 10/27/2022Salubris and Anlong Bio Enter Partnership for Small Nucleic Acid Dru...
  • 10/27/2022China NMPA Approval Tracker 09/2022 (PharmaDJ)
  • 10/27/2022Semiconductor Export Curbs Hitting China To Be Followed By Biotech and...
  • 10/26/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 10/26/2022NMPA Issues the Measures for the Administration of Drug Recalls (with ...
  • 10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...
  • 10/25/2022CDE Solicits Comments on Draft Technical Guidelines For Clinical Trial...
  • 10/25/2022CDE Solicits Comments on Draft Technical Guidelines for Pharmaceutical...
  • 10/25/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Safet...
  • Page:138/789 Total number of articles:23668: [First][<<] [136] [137] [138] [139] [140] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group